DB18642ExperimentalCell transplant therapies
OTL-102 consists of autologous CD34+ enriched cells that contain hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral vector encoding the human gp91phox gene. It is being investigated... It is being investigated for the treatment of X-linked chronic granulomatous disease.
- Also known as
- Autologous CD34+ enriched cell population that contains hematopoietic stem and progenitor cells transduced ex vivo using a lentiviral vector encoding the human gp91phox gene
- Code names
- OTL-102
Which companies are running trials of OTL-102, in which indications and phases, and which of those programs are still active?
Create a free account or log in to explore the full data card.
Create Account